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Abstract We examined the mechanism of DNA damage
induced by a mutagenic tyrosine metabolite, homogentisic acid
(HGA), using 32P-5P-end-labeled DNA fragments obtained from
the human p53 tumor suppressor gene. HGA caused DNA
damage in the presence of Cu(II), particularly at thymine and
cytosine residues. Catalase and bathocuproine inhibited the DNA
damage, suggesting the involvement of H2O2 and Cu(I). The
formation of 8-oxo-7,8-dihydro-2P-deoxyguanosine by HGA
increased depending on HGA concentration in the presence of
Cu(II). It is concluded that H2O2 is generated during Cu(II)-
catalyzed HGA autoxidation and reacts with Cu(I) to form the
Cu(I)-peroxide complex, capable of causing oxidative DNA
damage.
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1. Introduction
Dietary factors account for approximately 35% of cancers
attributed to environmental factors [1,2]. One possible exam-
ple of dietary carcinogenesis is the involvement of proteins,
amino acids and their metabolites. Epidemiological studies
have suggested that high protein intake is a risk factor for
several types of cancers, particularly colon, rectum and breast
cancers [3,4]. Signi¢cantly increased risks of renal cell cancer
were observed with increasing consumption of high protein
foods [5]. An animal experiment has demonstrated that high
protein intake enhanced the development of chemically in-
duced preneoplastic foci [6]. However, the mechanism of car-
cinogenesis caused by protein intake remains to be clari¢ed.
The possibility that tyrosine metabolites may participate in
carcinogenesis has been pointed out. It has been suggested
that tyrosine is a rate-limiting substrate for tumor cell prolif-
eration [7]. Tyrosine is metabolized to homogentisic acid
(HGA) through the formation of p-hydroxyphenylpyruvate
and p-hydroxyphenyllactic acid. HGA has been reported to
be mutagenic in bacteria and mammalian cells [8]. p-Hydroxy-
phenyllactic acid induced leukemic changes and hepatomas
in mice [9,10], suggesting that HGA may be involved in caus-
ing malignant tumors. A high incidence of hepatocarcinoma
was observed in patients with the chronic form of hereditary
tyrosinemia type I [9,11]. When HGA was administered or-
ally, the plasma level of HGA in carriers of hereditary tyro-
sinemia type I was signi¢cantly higher than that in controls
[12]. Therefore, accumulation of HGA in patients with this
disease may play an important role in causing malignant tu-
mors.
To investigate the involvement of HGA in carcinogenesis,
we examined DNA damage induced by HGA using 32P-5P-
end-labeled DNA fragments obtained from the human p53
tumor suppressor gene. It has been suggested that some diet-
ary factors can exert prooxidant actions [13,14] and may be
involved in oxidative DNA damage. Therefore, we measured
the formation of 8-oxo-7,8-dihydro-2P-deoxyguanosine (8-oxo-
dG), an indicator of oxidative damage to DNA, using an
electrochemical detector coupled to HPLC (HPLC-ECD).
2. Materials and methods
2.1. Materials
Restriction enzyme HindIII was purchased from New England Bio-
labs. Restriction enzymes (EcoRI and ApaI) and calf intestine phos-
phatase were from Boehringer Mannheim GmbH. [Q-32P]ATP (222
TBq/mmol) was from New England Nuclear. HGA was from Nacalai
Tesque Co. (Kyoto, Japan). Diethylenetriamine-N,N,NP,NQ,NQ-penta-
acetic acid (DTPA) and bathocuproine disulfonic acid were from Do-
jin Chemicals Co. (Kumamoto, Japan). Calf thymus DNA, superox-
ide dismutase (SOD, 3000 units/mg from bovine erythrocytes) and
catalase (45 000 units/mg from bovine liver) were from Sigma Chem-
ical Co. Nuclease P1 was from Yamasa Shoyu Co. (Chiba, Japan).
2.2. Preparation of 32P-5P-end-labeled DNA fragments
DNA fragments were obtained from the human p53 tumor suppres-
sor gene [15]. The 32P-5P-end-labeled 650-bp DNA fragment (HindIII*
13 972^EcoRI* 14 621) was obtained as described previously [16]. The
650-bp fragment was digested with ApaI to obtain a singly labeled
443-bp (ApaI 14 179^EcoRI* 14 621) and 211-bp (HindIII* 13 972^
ApaI 14 182) DNA fragments. The asterisk indicates 32P labeling.
2.3. Detection of damage to 32P-labeled DNA fragments
The standard reaction mixture in a microtube (1.5-ml Eppendorf)
contained HGA, [32P]DNA fragment and 10 WM/base sonicated calf
thymus DNA in 200 Wl of 10 mM sodium phosphate bu¡er (pH 7.8)
containing 5 WM DTPA. After incubation for 30 min at 37‡C, the
DNA fragments were heated at 90‡C in 1 M piperidine for 20 min and
treated as described previously [17,18]. The preferred cleavage sites
were determined by direct comparison of the positions of the oligo-
nucleotides with those produced by the chemical reactions of the
Maxam-Gilbert procedure [19] using a DNA-sequencing system
(LKB 2010 Macrophor). A laser densitometer (LKB 2222 UltroScan
XL) was used for the measurement of the relative amounts of oligo-
nucleotides from the treated DNA fragments.
2.4. Measurement of 8-oxodG formation by HGA
The amount of 8-oxodG was measured by a modi¢ed method of
Kasai et al. [20]. The reaction mixtures containing 100 WM/base calf
thymus DNA fragments, HGA and 20 WM CuCl2 in 4 mM sodium
phosphate bu¡er (pH 7.8) containing 2 WM DTPA were incubated for
30 min at 37‡C. After ethanol precipitation, DNA was digested to the
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nucleosides with nuclease P1 and calf intestine phosphatase, and an-
alyzed with an HPLC-ECD as described previously [21].
2.5. UV-visible spectra measurement
UV-visible spectra were measured at 37‡C with a UV-vis-NIR re-
cording spectrophotometer (Shimadzu UV-365). The reaction mixture
contained 100 WM HGA and 20 WM CuCl2 in 10 mM sodium phos-
phate bu¡er (pH 7.8) containing 5 WM DTPA. Spectral tracing was
initiated by addition of CuCl2.
3. Results
3.1. E¡ects of scavengers and bathocuproine on DNA damage
by HGA plus Cu(II)
Fig. 1 shows the autoradiogram showing the e¡ects of hy-
droxyl free radical (cOH) scavengers, catalase, SOD and bath-
ocuproine, a Cu(I)-speci¢c chelator, on DNA damage induced
by HGA plus Cu(II). HGA caused DNA damage in the pres-
ence of Cu(II) (lane 2), although DNA damage was not
caused by HGA alone or Cu(II) alone (data not shown).
HGA caused little or no DNA damage in the presence of
Fe(II), Fe(III) or Mn(II) (data not shown). DNA damage
was completely inhibited by catalase (lane 7) and 50 WM bath-
ocuproine (lane 10), suggesting that hydrogen peroxide
(H2O2) and Cu(I) were involved. Typical cOH scavengers,
ethanol, mannitol and sodium formate, did not inhibit DNA
damage (lanes 3^5), whereas methional showed an inhibitory
e¡ect (lane 6). SOD showed little or no inhibitory e¡ect on
DNA damage (lane 8). The intensity of DNA damage in-
creased depending on HGA concentration and incubation
time (data not shown). DNA damage was enhanced by piper-
idine treatment (data not shown), suggesting that HGA plus
Cu(II) caused not only strand breakage but also base damage
and liberation.
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Fig. 1. E¡ects of scavengers and bathocuproine on DNA damage
by HGA plus Cu(II). The reaction mixtures containing 32P-5P-end-
labeled 211-bp DNA fragments, 10 WM/base of sonicated calf thy-
mus DNA, 10 WM HGA and 20 WM CuCl2 in 200 Wl of 10 mM
phosphate bu¡er (pH 7.8) containing 5 WM DTPA were incubated
for 30 min at 37‡C. The DNA fragments were treated with 1 M pi-
peridine for 20 min at 90‡C and electrophoresed on an 8% poly-
acrylamide/8 M urea gel. The autoradiogram was obtained by ex-
posing an X-ray ¢lm to the gel. Control (lane 1) contained neither
HGA nor CuCl2. Scavenger or bathocuproine was added as fol-
lows: lane 2, no scavenger; lane 3, 5% ethanol; lane 4, 0.1 M man-
nitol; lane 5, 0.1 M sodium formate; lane 6, 0.1 M methional; lane
7, 150 units/ml catalase; lane 8, 150 units/ml SOD; lane 9, 20 WM
bathocuproine; lane 10, 50 WM bathocuproine.
Fig. 2. Site speci¢city of DNA cleavage induced by HGA in the presence of Cu(II). The reaction mixture contained the 32P-5P-end labeled 443-
bp (ApaI 14 179^EcoRI* 14 621) (A) or 211-bp DNA fragment (HindIII* 13 972^ApaI 14 182) (B), 10 WM/base of sonicated calf thymus DNA,
10 WM HGA and 20 WM CuCl2 in 200 Wl of 10 mM phosphate bu¡er (pH 7.8) containing 5 WM DTPA. After incubation for 30 min at 37‡C,
the DNA fragments were treated by the method described in the legend to Fig. 1. The relative amounts of DNA fragments were measured by
scanning the autoradiogram with a laser densitometer (LKB 2222 UltroScan XL). The horizontal axis shows the nucleotide number of the hu-
man p53 tumor suppressor gene. Underscoring, mutational hot spots in the p53 gene.
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3.2. Site speci¢city of DNA cleavage induced by HGA plus
Cu(II)
To examine the DNA cleavage sites, 32P-5P-end-labeled
DNA fragments treated with HGA plus Cu(II) and subse-
quently with piperidine were electrophoresed and an autora-
diogram was obtained as shown in Fig. 2. HGA induced
piperidine-labile sites particularly at thymine and cytosine res-
idues, although there remains a possibility that certain base
damage might be over- or underrepresented dependent on its
sensitivity to piperidine.
3.3. Formation of 8-oxodG induced by HGA
Using HPLC-ECD, we measured the contents of 8-oxodG
in calf thymus DNA treated with HGA, and the result is
shown in Fig. 3. The formation of 8-oxodG increased depend-
ing on HGA concentration in the presence of Cu(II). In the
absence of Cu(II), the content of 8-oxodG did not increase.
3.4. Changes in the UV-visible spectrum of HGA
In the presence of Cu(II), a rapid change in the spectrum of
HGA was observed and the maximum absorption at 248 nm
increased with time. Little or no spectral change was observed
in the absence of Cu(II) or in the presence of Fe(II) or Fe(III)
(data not shown).
4. Discussion
In the present study, we have demonstrated that a low
concentration of HGA induced damage to DNA fragments
obtained from the p53 tumor suppressor gene. Inhibitory ef-
fects of catalase and bathocuproine on DNA damage by
HGA plus Cu(II) suggest the involvement of H2O2 and
Cu(I). Typical cOH scavengers showed little or no inhibitory
e¡ect on DNA damage suggesting that cOH or, at least, free
cOH does not play an important role in DNA damage. The
DNA damage was inhibited by methional, which scavenges a
variety of free radicals including active species resembling cOH
[22,23]. HGA plus Cu(II) caused DNA damage at thymine
and cytosine residues. The site speci¢city supports the involve-
ment of active oxygen species other than cOH, because cOH
causes DNA cleavage at any nucleotides with little site specif-
icity [24,25].
The proposed mechanism of DNA damage induced by
HGA plus Cu(II) is shown in Fig. 4. HGA undergoes
Cu(II)-mediated oxidation to the semiquinone radical, which
would be further oxidized to benzoquinone acetate. It has
been reported that HGA undergoes oxygen-dependent autox-
idation to generate active oxygen species [26]. During the au-
toxidation of HGA, Cu(II) is reduced to Cu(I). Superoxide
anion (O32 ) is generated by the reaction of O2 with Cu(I) or
the semiquinone radical, and then dismutated to H2O2. H2O2
reacts with Cu(I) to form a crypto-OH radical, such as the
Cu(I)-peroxide complex, capable of causing site-speci¢c DNA
damage. However, there remains the possibility that the site
speci¢city of DNA damage can be conferred by binding of
copper to DNA at speci¢c sites.
HGA plus Cu(II) caused DNA damage at the cytosine res-
idue in the 5P-ACG-3P sequence, which is complementary to
the sequence of codon 273 (5P-CGT-3P). Codon 273 is known
to be a mutational hot spot of the p53 gene [27,28]. Oxidative
damage to DNA would participate in mutations of the p53
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Fig. 3. Formation of 8-oxodG induced by HGA plus Cu(II). The
reaction mixture contained 100 WM/base calf thymus DNA, HGA
and 20 WM CuCl2 in 400 Wl of 4 mM phosphate bu¡er (pH 7.8)
containing 2 WM DTPA. After incubation for 30 min at 37‡C, 0.2
mM DTPA was added to stop the reaction and the DNA was pre-
cipitated in ethanol. The DNA fragment was enzymatically digested
into nucleosides, and 8-oxodG formation was measured BY HPLC-
ECD.
Fig. 4. Proposed mechanism of DNA damage induced by HGA plus Cu(II).
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gene, leading to carcinogenesis. The present study demon-
strated that HGA caused oxidative DNA damage, including
the formation of 8-oxodG, an oxidative product of DNA, in
the presence of Cu(II). Shibutani et al. have reported that
formation of 8-oxodG causes DNA misreplication which
can lead to mutation, particularly GCT substitution [29].
Copper occurs in the mammalian cell nucleus, and may
contribute to high-order chromatin structures [30]. Copper
ion binds to non-histone proteins, and causes much stronger
ascorbate-mediated DNA damage than iron [31]. Copper has
the ability to catalyze the production of active oxygen species
and to mediate oxidative DNA damage [32^34]. These studies
support the observation that HGA caused DNA damage
through generation of active oxygen species by the interaction
with copper.
Alterations in amino acid metabolism can be caused by
high protein intake, amino acid-imbalanced diet and metabol-
ic disorders. A causal relationship between alterations in ami-
no acid metabolism and carcinogenesis has been suggested.
Disturbance of tyrosine metabolism is associated with carci-
nogenesis in patients with tyrosinemia [9,11]. Tyrosine metab-
olites, including HGA and its precursors, have shown muta-
genicity [8] and carcinogenicity [10]. This study has
demonstrated that HGA caused DNA damage by generating
active oxygen species. We have previously reported that cer-
tain tryptophan metabolites induced oxidative DNA damage
[35]. Abnormal tryptophan metabolism is associated with
bladder cancer [36,37]. There may be a number of amino
acid metabolites capable of causing oxidative DNA damage,
as well as HGA and tryptophan metabolites. Further inves-
tigation of the carcinogenic e¡ects of amino acid metabolites
is needed to clarify the mechanism of carcinogenesis induced
by dietary protein intake and disturbance of amino acid me-
tabolism.
References
[1] Doll, R. and Peto, R. (1981) J. Natl. Cancer Inst. 66, 1191^1308.
[2] Pitot, H.C. and Dragan, Y.P. (1996) in: Chemical Carcinogenesis
(Klaassen, C.D., Ed.), Casarett and Doull’s Toxicology: The
Basic Science of Poisons, pp. 201^267, McGraw-Hill, New York.
[3] Armstrong, B. and Doll, R. (1975) Int. J. Cancer 15, 617^631.
[4] Hems, G. (1978) Br. J. Cancer 37, 974^982.
[5] Chow, W.H., Gridley, G. and McLaughlin, J.K. (1994) J. Natl.
Cancer Inst. 86, 1131^1139.
[6] Youngman, L. and Campbell, T. (1992) Nutr. Cancer 18, 131^
142.
[7] Bartlett, D.L., Ste, T.P. and Torosian, M.H. (1995) Surgery 117,
260^267.
[8] Glatt, H. (1990) Mutat. Res. 238, 235^243.
[9] Laberge, C., Lescault, A. and Tanguay, R.M. (1986) Adv. Exp.
Med. Biol. 206, 209^221.
[10] Rauschenbach, M.O., Zharova, E.I., Sergeeva, T.I., Ivanova,
V.D. and Probatova, N.A. (1975) Cancer Res. 35, 577^585.
[11] Weinberg, A.G., Mize, C.E. and Worthen, H.G. (1976) J. Pe-
diatr. 88, 434^438.
[12] Laberge, C., Lescault, A., Grenier, A., Morrisette, J., Gagne, R.,
Gadbois, P. and Halket, J. (1990) Am. J. Hum. Genet. 47, 329^
337.
[13] Halliwell, B. (1996) Free Radical Res. 25, 57^74.
[14] Halliwell, B. (1996) Annu. Rev. Nutr. 16, 33^50.
[15] Chumakov, P. (1990) EMBL Data Library, accession number
X54156.
[16] Yamashita, N., Murata, M., Inoue, S., Hiraku, Y., Yoshinaga,
T. and Kawanishi, S. (1998) Mutat. Res. 397, 191^201.
[17] Yamamoto, K. and Kawanishi, S. (1991) J. Biol. Chem. 266,
1509^1515.
[18] Kawanishi, S. and Yamamoto, K. (1991) Biochemistry 30, 3069^
3075.
[19] Maxam, A.M. and Gilbert, W. (1980) Methods Enzymol. 65,
499^560.
[20] Kasai, H., Crain, P.F., Kuchino, Y., Nishimura, S., Ootsuyama,
A. and Tanooka, H. (1986) Carcinogenesis 7, 1849^1851.
[21] Ito, K., Inoue, S., Yamamoto, K. and Kawanishi, S. (1993)
J. Biol. Chem. 268, 13221^13227.
[22] Youngman, R.J. and Elstner, E.F. (1981) FEBS Lett. 129, 265^
268.
[23] Pryor, W.A. and Tang, R.H. (1978) Biochem. Biophys. Res.
Commun. 81, 498^503.
[24] Kawanishi, S., Inoue, S. and Sano, S. (1986) J. Biol. Chem. 261,
5952^5958.
[25] Celander, D.W. and Cech, T.R. (1990) Biochemistry 29, 1355^
1361.
[26] Martin Jr., J.P. and Batko¡, B. (1987) Free Radical Biol. Med. 3,
241^250.
[27] Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C.
(1991) Science 253, 49^53.
[28] Denissenko, M.F., Pao, A., Tang, M. and Pfeifer, G.P. (1996)
Science 274, 430^432.
[29] Shibutani, S., Takeshita, M. and Grollman, A.P. (1991) Nature
349, 431^434.
[30] Burkitt, M.J. (1994) Methods Enzymol. 234, 66^79.
[31] Chiu, S., Xue, L., Friedman, L.R. and Oleinick, N.L. (1995)
Biochemistry 34, 2653^2661.
[32] Kawanishi, S., Ito, K., Oikawa, S., Yamamoto, K. and Inoue, S.
(1994) in: Frontiers of Reactive Oxygen Species in Biology and
Medicine (Asada, K. and Yoshikawa, T., Eds.), pp. 153^156,
Excerpta Medica, Amsterdam.
[33] Guyton, K.Z. and Kensler, T.W. (1993) Br. Med. Bull. 49, 523^
544.
[34] Li, Y. and Trush, M.A. (1994) Cancer Res. 54, 1895s^1898s.
[35] Hiraku, Y. and Kawanishi, S. (1995) Carcinogenesis 16, 349^
356.
[36] Abul-Fadl, M.A.M. and Khalafallah, A.S. (1961) Br. J. Cancer
15, 478^482.
[37] Bryan, G.T. (1971) Am. J. Clin. Nutr. 24, 841^847.
FEBS 20586 30-7-98
Y. Hiraku et al./FEBS Letters 432 (1998) 13^1616
